Back to results
US 2011/0236387 A1Published application
Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
AssigneeAlexion Pharmaceuticals, Inc.
InventorsKATHERINE S. BOWDISH, ANKE KRETZ-ROMMEL
Life of this patent
Estimating the term…
Abstract
Small animal models for assessing immunomodulatory effects of compounds are provided.
Claims15
1-48. (canceled)
A method for treating cancer, said method comprising administering to a patient suffering from cancer an antibody, or an antigen-binding fragment thereof, that binds to OX-2/CD200, wherein OX-2/CD200 is upregulated in said cancer.
Dependencies are inferred from the claim text.